Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Pancreatic cyst development: insights from von Hippel-Lindau disease.

van Asselt SJ, de Vries EG, van Dullemen HM, Brouwers AH, Walenkamp AM, Giles RH, Links TP.

Cilia. 2013 Feb 5;2(1):3. doi: 10.1186/2046-2530-2-3.

2.

Histopathology and molecular genetics of multiple cysts and microcystic (serous) adenomas of the pancreas in von Hippel-Lindau patients.

Mohr VH, Vortmeyer AO, Zhuang Z, Libutti SK, Walther MM, Choyke PL, Zbar B, Linehan WM, Lubensky IA.

Am J Pathol. 2000 Nov;157(5):1615-21.

3.

Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.

Lubensky IA, Gnarra JR, Bertheau P, Walther MM, Linehan WM, Zhuang Z.

Am J Pathol. 1996 Dec;149(6):2089-94.

4.

Pancreatic endocrine microadenomatosis in patients with von Hippel-Lindau disease: characterization by VHL/HIF pathway proteins expression.

PĂ©rigny M, Hammel P, Corcos O, Larochelle O, Giraud S, Richard S, Sauvanet A, Belghiti J, Ruszniewski P, Bedossa P, Couvelard A.

Am J Surg Pathol. 2009 May;33(5):739-48. doi: 10.1097/PAS.0b013e3181967992.

PMID:
19238077
5.

Genetic study of a large Chinese kindred with von Hippel-Lindau disease.

Huang YR, Zhang J, Wang JD, Fan XD.

Chin Med J (Engl). 2004 Apr;117(4):552-7.

PMID:
15109448
6.

High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis.

Lott ST, Chandler DS, Curley SA, Foster CJ, El-Naggar A, Frazier M, Strong LC, Lovell M, Killary AM.

Cancer Res. 2002 Apr 1;62(7):1952-5.

7.

Von Hippel-Lindau syndrome. A pleomorphic condition.

Friedrich CA.

Cancer. 1999 Dec 1;86(11 Suppl):2478-82. Review.

PMID:
10630173
8.

Deciphering von Hippel-Lindau (VHL/Vhl)-associated pancreatic manifestations by inactivating Vhl in specific pancreatic cell populations.

Shen HC, Adem A, Ylaya K, Wilson A, He M, Lorang D, Hewitt SM, Pechhold K, Harlan DM, Lubensky IA, Schmidt LS, Linehan WM, Libutti SK.

PLoS One. 2009;4(4):e4897. doi: 10.1371/journal.pone.0004897. Epub 2009 Apr 2.

9.

Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.

Kley N, Whaley J, Seizinger BR.

Glia. 1995 Nov;15(3):297-307. Review.

PMID:
8586465
10.

[Familial and genetic study in a large Chinese kindred with von Hippel-Lindau disease and gene mutation analysis].

Zhang J, Huang YR, Wang JD, Fan XD.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004 Feb;21(1):5-9. Chinese.

PMID:
14767899
11.

Abdominal visceral lesions in von Hippel-Lindau disease: incidence and clinical behavior of pancreatic and adrenal lesions at a single center.

Delman KA, Shapiro SE, Jonasch EW, Lee JE, Curley SA, Evans DB, Perrier ND.

World J Surg. 2006 May;30(5):665-9.

PMID:
16617420
12.

Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel Lindau disease.

Seizinger BR, Smith DI, Filling-Katz MR, Neumann H, Green JS, Choyke PL, Anderson KM, Freiman RN, Klauck SM, Whaley J, et al.

Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2864-8.

13.
14.

Imaging findings of pancreatic cystic lesions in von Hippel-Lindau disease.

Kobayashi N, Sato T, Kato S, Watanabe S, Hosono K, Shimamura T, Iida H, Endo H, Koide T, Takahashi H, Yoneda M, Shibata W, Abe Y, Inamori M, Kirikoshi H, Saito S, Maeda S, Nakajima A, Kubota K.

Intern Med. 2012;51(11):1301-7. Epub 2012 Jun 1.

15.

Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d'Etude de la Maladie de von Hippel-Lindau.

Hammel PR, Vilgrain V, Terris B, Penfornis A, Sauvanet A, Correas JM, Chauveau D, Balian A, Beigelman C, O'Toole D, Bernades P, Ruszniewski P, Richard S.

Gastroenterology. 2000 Oct;119(4):1087-95.

PMID:
11040195
16.

A variety of phenotype with R161Q germline mutation of the von Hippel-Lindau tumor suppressor gene in Japanese kindred.

Iida K, Okimura Y, Takahashi K, Inomata S, Iguchi G, Kaji H, Chihara K.

Int J Mol Med. 2004 Mar;13(3):401-4.

PMID:
14767570
17.

[Von-Hippel-Lindau (VHL) protein function by initiation and progression of renal cancer].

Moch H.

Pathologe. 2008 Nov;29 Suppl 2:149-52. doi: 10.1007/s00292-008-1034-y. Review. German.

PMID:
18751708
18.

The von Hippel-Lindau tumor suppressor gene and kidney cancer.

Kaelin WG Jr.

Clin Cancer Res. 2004 Sep 15;10(18 Pt 2):6290S-5S. Review.

19.

Pancreatic lesions in von Hippel-Lindau disease? A systematic review and meta-synthesis of the literature.

Charlesworth M, Verbeke CS, Falk GA, Walsh M, Smith AM, Morris-Stiff G.

J Gastrointest Surg. 2012 Jul;16(7):1422-8. doi: 10.1007/s11605-012-1847-0. Epub 2012 Feb 28. Review.

PMID:
22370733
20.

Pancreatic lesions in von Hippel-Lindau disease: prevalence, clinical significance, and CT findings.

Hough DM, Stephens DH, Johnson CD, Binkovitz LA.

AJR Am J Roentgenol. 1994 May;162(5):1091-4.

PMID:
8165988
Items per page

Supplemental Content

Write to the Help Desk